In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Healthy young adults may work-out less intensely wearing cloth masks

By Linda Carroll (Reuters Health) - Cloth masks worn by healthy young adults during intense workouts leads to lower exercise capacity and greater perceived discomfort, a small study suggests. An

Majority of Brazil COVID-19 ICU patients aged 40 years or younger - report

By Reuters Staff RIO DE JANEIRO (Reuters) - The surging COVID-19 outbreak in Brazil is increasingly affecting younger people, with hospital data showing that last month the majority of those in

One in four parents say youth sports don't consistently enforce COVID-19 precautions

By Lisa Rapaport (Reuters Health) - Even though the majority of parents give youth sports leagues high marks for keeping them informed about COVID-19 safety protocols, more than one in four parents

Self-report smell loss tool could be useful for COVID-19 symptom screening

By Marilynn Larkin NEW YORK (Reuters Health) - A novel self-administered olfactory test, SCENTinel, identifies individuals with smell loss and will likely be useful for COVID-19 symptom screening and

U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots

By Julie Steenhuysen and Kate Kelland CHICAGO/LONDON (Reuters) - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood clots in the brain, U.S. government

Comfort care for stroke on the rise in the U.S., tied to lower costs

By Marilynn Larkin NEW YORK (Reuters Health) - Comfort-care interventions among ischemic-stroke patients increased in the U.S. from 2006 to 2015 and were associated with lower adjusted costs,

Moderna says protection from its COVID-19 vaccine still strong six months on

By Michael Erman NEW YORK (Reuters) - Moderna Inc said on Tuesday that its COVID-19 vaccine still showed strong protection against the illness six months after people received their second shot, with

Breastfeeding safe for mothers with COVID-19 infection

By Reuters Staff NEW YORK (Reuters Health) - SARS-CoV-2 is unlikely to be transmitted to newborns via breast milk, according to a study from Israel, which supports the current guidance from the World

UPDATE 1-Ohio can enforce ban on Down syndrome abortions - U.S. appeals court

(Adds detail, Ohio attorney general comment) By Jonathan Stempel (Reuters) - A federal appeals court ruled on Tuesday that Ohio can enforce a 2017 law banning abortions when medical tests show that a

Mexican-made COVID-19 vaccine could be ready this year

By Cassandra Garrison MEXICO CITY (Reuters) - Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, a senior official said on Tuesday, an

BPCA-funded studies have racial, ethnic diversity

By Lisa Rapaport (Reuters Health) - Studies and clinical trials funded by the Best Pharmaceuticals for Children Act (BPCA) generally enroll youth from a variety of racial and ethnic groups at

South Africa suspends J&J vaccine rollout after U.S. pause

By Alexander Winning JOHANNESBURG (Reuters) - South Africa has suspended the rollout of Johnson & Johnson's (J&J) COVID-19 vaccine, its health minister said on Tuesday, after U.S. federal health

Canada talking to J&J about vaccine setback as PM frets over virus variants

By Steve Scherer and David Ljunggren OTTAWA (Reuters) - Canada said on Tuesday it was talking to Johnson & Johnson about reports that its COVID-19 vaccine might cause rare blood clots, while Prime

EU seeking clarification from J&J after rollout delay news - source

By Francesco Guarascio BRUSSELS (Reuters) - The European Commission is seeking clarification from Johnson & Johnson about the company's "completely unexpected" announcement of delays in COVID-19

Sweden's COVID infections among highest in Europe, with 'no sign of decrease'

By Johan Ahlander STOCKHOLM (Reuters) - The rate of new COVID-19 infections in Sweden has jumped to the second-highest in Europe after land-locked San Marino, data showed on Tuesday, as the

Austrian health minister says he is stepping down, exhausted

By Reuters Staff VIENNA (Reuters) - Austrian Health Minister Rudolf Anschober of the Greens, the junior partner in the conservative-led coalition, said on Tuesday he is stepping down, exhausted and

Ohio can enforce ban on Down syndrome abortions - U.S. appeals court

By Reuters Staff (Reuters) - A federal appeals court ruled on Tuesday that Ohio can enforce a 2017 law banning abortions when medical tests show that a fetus has Down syndrome. In a 9-7 decision, the

How computer mapping could help Biden find and fix polluted neighborhoods

By Valerie Volcovici (Reuters) - Diagnosed with asthma at 8 years old, Karlaine Francisco grew up thinking everyone had it. Her friends in south Stockton, California, also carried inhalers and

UPDATE 3-U.S. calls for pause to J&J COVID-19 vaccine over rare blood clots

(Adds more FDA comments) By Manas Mishra and Michael Erman (Reuters) - U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine for at least a few

Still not enough evidence to support or reject screening adults for vitamin D deficiency: USPSTF

By Reuters Staff NEW YORK (Reuters Health) - There remains insufficient evidence to recommend for or against screening for vitamin D deficiency in asymptomatic adults, according to an update from the

Pembrolizumab may be preferable to chemo in certain patients with gastroesophageal cancer

By David Douglas NEW YORK (Reuters Health) - Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction cancer, according

Healthy lifestyle may protect against lethal prostate cancer in men at high genetic risk

By Megan Brooks NEW YORK (Reuters Health) - Maintaining a healthy lifestyle may reduce the risk of lethal prostate cancer in men at high genetic risk for developing the disease, according to new

UPDATE 2-U.S. calls for pause to J&J COVID-19 vaccine over rare blood clots

(Adds comments from FDA briefing) By Manas Mishra and Michael Erman (Reuters) - U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after after

AstraZeneca shot is good if safety issues can be overcome, U.S. official Fauci says

By Reuters Staff LONDON (Reuters) - U.S. infectious disease official Anthony Fauci said AstraZeneca's COVID-19 vaccine had good efficacy, but safety concerns needed to be straightened out and it might

EXPLAINER-How worried should we be about blood clots linked to AstraZeneca and J&J vaccines?

By John Miller and Ludwig Burger ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson's COVID-19 vaccine, as they investigate rare blood clotting in six women. J&J

UPDATE 1-U.S. calls for pause to J&J COVID-19 vaccine over rare blood clots

(Adds J&J delaying rollout of vaccine in Europe, White House comments, background) By Manas Mishra and Michael Erman (Reuters) - U.S. federal health agencies on Tuesday recommended pausing the use of

Australia reports second Astrazeneca blood clot case, vaccine rollout steady

By Renju Jose SYDNEY (Reuters) - Australia said on Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise in inoculation

Novavax says supply shortages delaying full-speed production of its COVID-19 vaccine

By Carl O'Donnell (Reuters) - Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages

UK's Johnson warns lockdown, not vaccines, behind drop in COVID deaths

By Alistair Smout and Sarah Young LONDON (Reuters) - British Prime Minister Boris Johnson warned on Tuesday that the rapid drop in COVID-19 deaths was largely down to a three-month lockdown, not the

British variant of COVID-19 not as severe as feared - study

By Reuters Staff (Reuters) - A highly contagious variant of COVID-19 first identified in Britain does not cause more severe disease in hospitalised patients, according to a new study published in the

U.S. calls for pause to J&J COVID-19 vaccine over rare blood clots

By Reuters staff (Reuters) - U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six recipients developed a rare disorder involving blood

Transgender patients get cancer diagnosed at later stages, often have worse survival

By Lisa Rapaport (Reuters Health) - Transgender individuals are more likely to receive certain cancer diagnoses at later stages and less likely to receive treatment for some malignancies, contributing

Digital exercise intervention helps improve knee osteoarthritis

By Lisa Rapaport (Reuters Health) - Patients with knee osteoarthritis who participate in a self-directed digital exercise program may experience more symptom improvement than without this support, a

Study suggests physician gender might impact influenza vaccine administration

By Lisa Rapaport (Reuters Health) - Female physicians may be slightly more likely than their male counterparts to administer the influenza vaccine to Medicare enrollees, a new study suggests.

Common blood pressure medications linked to increased skin cancer risk

By Linda Carroll (Reuters Health) - Thiazide diuretics, which are used by many older patients to control blood pressure, are linked to increased risk of certain skin cancers in a new Canadian study.

Dynamic model of the SARS-CoV-2 spike protein reveals novel potential vaccine targets

By Marilynn Larkin NEW YORK (Reuters Health) - Dynamic molecular simulations that captured the structure and movements of the SARS-CoV-2 spike protein have revealed novel potential vaccine targets and

Novel assay promising for rapid detection of Ebola virus in low-resource settings

By Marilynn Larkin NEW YORK (Reuters Health) - A new, highly sensitive point-of-care immunoassay called D4 may facilitate earlier detection of Ebola outbreaks, particularly in low-resource settings,

Microsoft to buy AI firm Nuance for $16 bln to boost healthcare business

By Chavi Mehta and Krystal Hu (Reuters) - Microsoft Corp said on Monday it would buy artificial intelligence and speech technology firm Nuance Communications Inc for about $16 billion, as it builds

Germany to make regular COVID-19 tests compulsory for firms - draft law

By Reuters Staff BERLIN (Reuters) - German companies will be obliged to offer staff regular COVID-19 self-testing kits at least once a week, according to a draft amendment to occupational health and

Italian region rejects Draghi's 'stupid' vaccine guidelines

By Reuters Staff ROME (Reuters) - The head of Italy's southern Campania region said on Monday he would ignore a government order to give the elderly vaccination priority and would instead focus on

France extends gap between mRNA vaccine shots to ramp-up rollout

By Reuters Staff PARIS (Reuters) - France will lengthen the period between the first and second shots of mRNA anti-COVID vaccines to six weeks from four weeks as of April 14 to accelerate the

China considers mixing COVID-19 vaccines to boost protection rate

By Reuters Staff BEIJING (Reuters) - China's top disease control official has said the country is formally considering mixing COVID-19 vaccines as a way of further boosting vaccine efficacy. Available

Overuse of radioactive iodine for low-risk thyroid cancer appears common

By Scott Baltic NEW YORK (Reuters Health) - The use of radioactive iodine to treat low-risk thyroid cancer, which may conflict with clinical guidelines, appears to be common, a new U.S. survey

Ontario hospitals may have to withhold care as COVID-19 fills ICUs

By Allison Martell and Anna Mehler Paperny TORONTO (Reuters) - Doctors in the Canadian province of Ontario may soon have to decide who can and cannot receive treatment in intensive care as the number

Coronavirus pandemic 'a long way from over', WHO's Tedros says

By Reuters Staff GENEVA (Reuters) - Confusion and complacency in addressing COVID-19 means the pandemic is a long way from over, but it can be brought under control in months with proven public health

Native health providers drive Alaska's vaccination success story

By Yereth Rosen ANCHORAGE, Alaska (Reuters)Despite its sprawling geography and often-inhospitable climate, Alaska ranks among the top U.S. states for getting COVID-19 vaccine into the arms of its

AstraZeneca's diabetes drug Farxiga fails in COVID-19 study

By Reuters Staff (Reuters) - Data from a late-stage study to test if AstraZeneca's diabetes drug Farxiga could treat patients hospitalised with COVID-19 and at risk of developing serious complications

Regeneron to seek U.S. OK for COVID-19 cocktail to be used for prevention

By John Miller ZURICH (Reuters) - Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections

Asthma drug budesonide speeds recovery for at-home COVID-19 patients

By Kate Kelland LONDON (Reuters) - Treating COVID-19 patients at home with a commonly-used inhaled asthma drug called budesonide can speed up their recovery, according to UK trial results on Monday

South African variant may evade protection from Pfizer vaccine, Israeli study says

By Maayan Lubell JERUSALEM (Reuters) - The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data

Investigational drug could have disease-modifying effect in sickle cell disease

By Megan Brooks NEW YORK (Reuters Health) - An investigational small molecule discovered by scientists at Fulcrum Therapeutics has the potential to address the root cause of sickle cell disease, early

Time-limited trials may have benefits in critically ill patients

By Reuters Staff NEW YORK (Reuters Health) - For critically ill patients in the intensive-care unit (ICU), time-limited trials (TLTs) for care planning appear to improve communication with family and

Pediatric neuroblastoma may be inherited more often than thought

By Megan Brooks NEW YORK (Reuters Health) - New research suggests that "sporadic" neuroblastoma in children may actually be inherited more often that thought. The study identified pathogenic or likely

Survival doubled in phase-1 test of childhood glioma therapy

By Gene Emery NEW YORK (Reuters Health) - Children plagued by brain tumors and treated with a genetically engineered virus had a median overall survival more than double the 5.6 months historically

'The right path' - Chile defends Sinovac use amid fresh efficacy questions

By Aislinn Laing SANTIAGO, April 11 (Reuters) - Chilean authorities on Sunday backed the country's widespread use of the COVID-19 vaccine manufactured by Chinese firm Sinovac after China's top disease

Insulin pump, continuous glucose monitoring benefit youth with TD1

By Lisa Rapaport (Reuters Health) - Children and teens with type 1 diabetes may have lower blood pressure and a reduced risk of diabetic ketoacidosis when they use an insulin pump , continuous glucose

World Bank says to commit $2 bln to vaccines in developing countries by end-April

By David Lawder WASHINGTON (Reuters) - The World Bank Group will have committed $2 billion in financing by the end of April for COVID-19 vaccines in some 40 developing countries, World Bank Managing

COVID-19 pandemic exacerbates challenges with U.S. blood supply

By Lisa Rapaport (Reuters Health) - The COVID-19 pandemic has led to a blood supply shortage in the U.S. mainly due to halted blood drives and stay-at-home orders, and not due to increased transfusion

Anaphylaxis case after mRNA vaccination traced to polyethylene glycol allergy

By Linda Carroll (Reuters Health) - An undiagnosed polyethylene glycol allergy was at the root of at least one anaphylaxis case associated with an mRNA-based COVID-19 vaccine, a UK report suggests.

Novel genomic alterations in circulating tumor cells tied to castrate-resistant prostate cancer

By Marilynn Larkin NEW YORK (Reuters Health) - Novel genomic alterations in circulating tumor cells (CTCs) - beyond the androgen receptor (AR)-V7 splice variant - are associated with outcomes and

Permanent pacemaker implantation after TAVI likely lower in women than men

By Marilynn Larkin NEW YORK (Reuters Health) - Women are less likely than men to get a permanent pacemaker after transcatheter aortic-valve implantation (TAVI), unless a balloon-expandable valve is

Pfizer, BioNTech seek U.S. emergency nod for COVID-19 vaccine in adolescents

By Michael Erman and Mrinalika Roy (Reuters) - Pfizer Inc and its German partner BioNTech SE on Friday asked U.S. regulators to allow the emergency use of their vaccine in adolescents aged 12 to 15.

Chemically sterilized pacifiers tied to increased risk of food allergy

By Reuters Staff NEW YORK (Reuters Health) - Sterilizing baby pacifiers with chemical antiseptics may compromise immunity and contribute to the development of food allergies, according to a study from

REFILE-More evidence MIS-C is a delayed response to SARS-CoV-2

(Adds byline) By Megan Brooks NEW YORK (Reuters Health) - An analysis of geographic and temporal trends in multisystem inflammatory syndrome in children (MIS-C) support the view that MIS-C results

UPDATE 1-Unwanted vaccines needed to help poor countries catch up, international health officials say

(Updates throughout) By Stephanie Nebehay and Douglas Busvine (Reuters) - Doses of vaccines rejected as countries fine-tune their inoculation campaigns will go to poor countries where possible to

UPDATE 1-J&J COVID-19 vaccine under EU review over blood clots

(Recasts, adds details, expert comment) By Pushkala Aripaka and Julie Steenhuysen (Reuters) - Europe's drug regulator said on Friday that it is reviewing rare blood clots in four people in the United

Arrest videos undercut Derek Chauvin's murder trial defense, pathologist tells jury

By Jonathan Allen MINNEAPOLIS (Reuters) - A forensic pathologist testified on Friday that the sheer volume of videos of George Floyd's arrest helped confirm the finding that oxygen deprivation caused

EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022 -EU source

By Reuters Staff BRUSSELS (Reuters) - The European Commission is seeking EU governments' approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19

Families thwart COVID-19 patient transfers as third wave grips France

By Caroline Pailliez PARIS (Reuters) - In March, emergency room doctor Frederic Adnet needed to move COVID-19 patients from his fast-filling Paris hospital to less hard-hit regions of France to free

J&J COVID-19 vaccine under EU review over blood clots, AstraZeneca probe grows

By Pushkala Aripaka and Manas Mishra (Reuters) - Europe's drug regulator said it is reviewing reports of rare blood clots in four people who received Johnson & Johnson's COVID-19 vaccine and has

More evidence MIS-C is a delayed response to SARS-CoV-2

By Reuters Staff NEW YORK (Reuters Health) - An analysis of geographic and temporal trends in multisystem inflammatory syndrome in children (MIS-C) support the view that MIS-C results from delayed

Aflibercept may curb complications of diabetic retinopathy

By David Douglas NEW YORK (Reuters Health) - Aflibercept (Eylea, Regeneron) injections do not appear to improve visual acuity, but may reduce complications threatening vision in patients with diabetic

Adjustable stent retriever effective in acute ischemic stroke

By Reuters Staff NEW YORK (Reuters Health) - The Tigertriever (Rapid Medical), a new, radially adjustable stent-retrieve device, compares well with established "stentrievers" in achieving successful

HER2 results in gastric cancer often differ between labs with implications for treatment

By Reuters Staff NEW YORK (Reuters Health) - In more than one of five patients with metastatic gastric cancer (mGC), results of human epidermal growth factor receptor-2 (HER2) testing by local and

Merkel to take control from German states in pandemic battle

By Andreas Rinke and Caroline Copley BERLIN (Reuters) - German Chancellor Angela Merkel plans to take control from federal states to impose restrictions on regions with high numbers of new coronavirus

INSIGHT-Italy's old pay high price for regional vaccine lottery

By Crispian Balmer and Angelo Amante ROME (Reuters) - Agostino Airaudo, 86, died of the coronavirus on March 21. Ninety minutes earlier he had received an SMS telling him that, after weeks of waiting,

Countries emphasise importance of AstraZeneca shot as they look to alternatives

By Byron Kaye and Twinnie Siu (Reuters) - Australia said on Friday it had ordered more alternatives for the AstraZeneca vaccine, setting back its vaccination rollout, and Hong Kong delayed deliveries

France opts for mRNA vaccines for second coronavirus shot

By Sudip Kar-Gupta and Benoit Van Overstraeten PARIS (Reuters) - France's top health advisory body in charge of COVID-19 vaccines recommended on Friday that recipients of a first dose of the

Vaccine rollout in England prevented 10,400 deaths by end-March, study says

By Reuters Staff LONDON (Reuters) - England's fast rollout of COVID-19 vaccines prevented over 10,000 deaths of people aged 60 and older by the end of March, according to an analysis by Public Health

Riociguat an option for pulmonary arterial hypertension when PDE-5 inhibitors fail

By Marilynn Larkin NEW YORK (Reuters Health) - Patients with pulmonary arterial hypertension (PAH) at intermediate risk of death within a year may be switched from a phosphodiesterase-5 (PDE-5)

Bevacizumab an option for diabetic macular edema

By Marilynn Larkin NEW YORK (Reuters Health) - Bevacizumab improved visual acuity and central subfield thickness (CST) in a retrospective analysis of diabetic macular edema patients. "Use of

Clinicians overestimate probability of diagnosis for common diseases

By Lisa Rapaport (Reuters Health) - Clinicians may overestimate the probability that patients will be diagnosed with diseases commonly seen in primary care, a new study suggests. Researchers asked 723

Many dermatologists to continue telehealth visits after pandemic

By Lisa Rapaport (Reuters Health) - While most U.S. dermatologists did not use telemedicine before the COVID-19 pandemic, a new study suggests many who did deploy virtual visits over the past year

EXCLUSIVE-French health body to say mRNA vaccine should be used as second dose after AstraZeneca

By Matthias Blamont PARIS (Reuters) - France's top health body will on Friday say that recipients of a first dose of AstraZeneca's traditional COVID-19 vaccine who are under 55 should get a second

Ocular abnormalities not likely in newborns of SARS-CoV-2-infected mothers

By Linda Carroll (Reuters Health) - Unlike pathogens such as Cytomegalovirus and Zika, SARS-CoV-2 is not likely to cause ocular problems in newborns whose mothers were infected with the virus during

UPDATE 1-Lack of oxygen from police restraint killed Floyd, doctor testifies at Chauvin murder trial

(Adds quotes, details from expert witness's testimony) By Jonathan Allen MINNEAPOLIS (Reuters) - A critical care doctor called as a prosecution witness in Derek Chauvin's murder trial testified on

Lack of oxygen from police restraint killed Floyd, doctor testifies at Chauvin murder trial

By Jonathan Allen MINNEAPOLIS (Reuters) - A critical care doctor called as a prosecution witness in Derek Chauvin's murder trial testified on Thursday that George Floyd died from a lack of oxygen

REFILE-Transplant saves selected patients with irreversible COVID-19 lung disease

(Changes "medium" to "median" in para 8 of story posted April 7.) By Ronnie Cohen (Reuters Health) - Double lung transplants are the only known way to save the lives of people with acute respiratory

UPDATE 1-Russia calls on Slovakia to return Sputnik V doses after dispute

(Recasts to focus on Russian response) By Reuters Staff PRAGUE (Reuters) - Russia called on Slovakia on Thursday to return hundreds of thousands of doses of the Sputnik V coronavirus vaccine, citing

AstraZeneca woes grow as Australia, Philippines, African Union curb COVID shots

By Reuters Staff (Reuters) - Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the Africa Union dropped plans to buy the shot, dealing further blows to the

Topical calcineurin inhibitors pose very little cancer risk

By David Douglas NEW YORK (Reuters Health) - The topical calcineurin inhibitors (TCIs) tacrolimus and pimecrolimus, widely used to treat atopic dermatitis, do not have any association with common

Some older people with multiple myeloma can safely skip long-term steroids

By Scott Baltic NEW YORK (Reuters Health) - In older, intermediate-fit patients newly diagnosed with multiple myeloma and receiving lenalidomide-dexamethasone (Rd) therapy, lenalidomide can be safely

UPDATE 1-Brazil detects first case of South African variant as COVID-19 deaths soar

(Adds possible Belo Horizonte variant, vaccine bill passing to Senate) By Eduardo Simões and Pedro Fonseca RIO DE JANEIRO (Reuters) - Brazil has recorded its first confirmed case of the highly

Slovak watchdog says Sputnik V producer did not provide requested data

By Reuters Staff PRAGUE (Reuters) - Slovakia's drug agency said on Thursday that makers of Russia's Sputnik V vaccine had failed to provide requested data on shipments that it said differed from those

Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine

By Reuters Staff SAO PAULO (Reuters) - Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for a new COVID vaccine developed by Canada's Medicago R&D

European court backs Czech Republic's requirement to vaccinate children

By Reuters Staff PRAGUE (Reuters) - The European Court of Human Rights (ECHR) accepts the Czech Republic's position on mandatory vaccinations for children, it said in a landmark ruling on Thursday

Scientists call for new probe into COVID-19 origins - with or without China

By Reuters Staff SHANGHAI (Reuters) - A joint China-World Health Organization (WHO) study into COVID-19 has provided no credible answers about how the pandemic began, and more rigorous investigations

New research provides lessons for clinical-trial design in Friedreich's ataxia

By Reuters Staff NEW YORK (Reuters Health) - New data provide insights into clinical and functional changes over four years in a large cohort of patients with genetically confirmed Friedreich's ataxia

Black Americans underrepresented in clinical trials of cardiovascular drugs

By Carolyn Crist NEW YORK (Reuters Health) - Black U.S. residents have been significantly underrepresented in pivotal clinical trials of 24 cardiovascular drugs that received Food and Drug

Chemoprevention with low-dose aspirin promising in familial adenomatous polyposis

By Reuters Staff NEW YORK (Reuters Health) - Low-dose aspirin can suppress the recurrence of colorectal polyps larger than 5.0 mm in patients with familial adenomatous polyposis (FAP), according to

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.

© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information